Content validity of the National Comprehensive Cancer Network – Functional Assessment of Cancer Therapy – Breast Cancer Symptom Index (NFBSI-16) and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form with advanced breast cancer patients

Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial

(2016) N. Harbeck et al.   ANNALS OF ONCOLOGY

Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients

(2015) Roxanne E. Jensen et al.   QUALITY OF LIFE RESEARCH

Living with Metastatic Breast Cancer: A Qualitative Analysis of Physical, Psychological, and Social Sequelae

(2013) Catherine E. Mosher et al.   Breast Journal

Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial

(2013) Howard A. Burris et al.   CANCER

1st International consensus guidelines for advanced breast cancer (ABC 1)

(2012) F. Cardoso et al.   BREAST

Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients

(2011) Kathleen J. Yost et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

(2011) José Baselga et al.   NEW ENGLAND JOURNAL OF MEDICINE

Symptom Management in Metastatic Breast Cancer

(2011) W. Irvin et al.   ONCOLOGIST

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding

(2011) Donald L. Patrick et al.   VALUE IN HEALTH

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument

(2011) Donald L. Patrick et al.   VALUE IN HEALTH

Priority Symptoms in Advanced Breast Cancer: Development and Initial Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)

(2011) Sofia F. Garcia et al.   VALUE IN HEALTH

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008

(2010) David Cella et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The daily impact of pain from metastatic breast cancer on spousal relationships: A dyadic electronic diary study

(2010) Hoda Badr et al.   PAIN

Progress in Assessing Physical Function in Arthritis: PROMIS Short Forms and Computerized Adaptive Testing

(2009) J. F. FRIES et al.   JOURNAL OF RHEUMATOLOGY

Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS)

(2008) M. Rose et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY